Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines that has been enhancing people’s health and well-being for more than 110 years, has announced it has been included in the Dow Jones Sustainability World Index for the second consecutive year and the Dow Jones Sustainability Europe Index for the third straight year.
